| Neely M, Kovacs A
Managing treatment-experienced pediatric and adolescent HIV patients: role of darunavir. [Journal Article]
Ther Clin Risk Manag 2009 Jun; 5(3):595-615.
Abstract | Full Citation | | Martin J, Deslandes G, Dailly E, et al.
A liquid chromatography-tandem mass spectrometry assay for quantification of nevirapine, indinavir, atazanavir, amprenavir, saquinavir, ritonavir, lopinavir, efavirenz, tipranavir, darunavir and maraviroc in the plasma of patients infected with HIV. [JOURNAL ARTICLE]
J Chromatogr B Analyt Technol Biomed Life Sci 2009 Aug 3.
Abstract | Full Citation | Find Related Articles | | Hughes CA, Robinson L, Tseng A, et al.
New antiretroviral drugs: a review of the efficacy, safety, pharmacokinetics, and resistance profile of tipranavir, darunavir, etravirine, rilpivirine, maraviroc, and raltegravir. [JOURNAL ARTICLE]
Expert Opin Pharmacother 2009 Aug 13.
Abstract | Full Citation | Find Related Articles | | Pham PA, la Porte CJ, Lee LS, et al.
Differential Effects of Tipranavir plus Ritonavir on Atorvastatin or Rosuvastatin Pharmacokinetics in Healthy Volunteers. [JOURNAL ARTICLE]
Antimicrob Agents Chemother 2009 Aug 10.
Abstract | Full Citation | | Imaz A, Del Saz SV, Ribas MA, et al.
Raltegravir, Etravirine, and Ritonavir-Boosted Darunavir: A Safe and Successful Rescue Regimen for Multidrug-Resistant HIV-1 Infection. [JOURNAL ARTICLE]
J Acquir Immune Defic Syndr 2009 Aug 3.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Etravirine: new drug. Multidrug-resistant HIV: another option. [Journal Article]
Prescrire Int 2009 Jun; 18(101):102-3.
Abstract | Full Citation | | Saracino A, Monno L, Tartaglia A, et al.
Clinical validation and applicability of different tipranavir/ritonavir genotypic scores in HIV-1 protease inhibitor-experienced patients. [Journal Article, Research Support, Non-U.S. Gov't]
Curr HIV Res 2009 Jul; 7(4):425-33.
Abstract | Full Citation | Find Related Articles | | Morello J, De Mendoza C, Soriano V, et al.
Use of different inhibitory quotients to predict early virological response to Tipranavir in antiretroviral experienced HIV patients. [JOURNAL ARTICLE]
Antimicrob Agents Chemother 2009 Jul 13.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Arribas JR
[Role of the new molecules in antiretroviral therapy. Position of raltegravir] [English Abstract, Journal Article]
Enferm Infecc Microbiol Clin 2008 Nov.:53-9.
Abstract | Full Citation | Find Related Articles | | Placeres Alsina MM, Tuset Creus M, Miró JM
[Pharmacokinetics and interactions of raltegravir] [English Abstract, Journal Article]
Enferm Infecc Microbiol Clin 2008 Nov.:23-8.
Abstract | Full Citation |    |
|
| |
Advertise on this site.
|
